Can-Fite Biopharma Overview
Can-Fite Biopharma Target Price
Analysts' 12-month price predictions for CANF.
Get informed when a big investor buys or sells
+ FollowShare Price
$3.28
Average Target Price
$6.50
98.2% upside
98.2% upside2 analysts in the last 4 months
High: $8 | Low: $5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-02 | H.C. Wainwright | $8 | 143.9% upside |  |
| 2026-05-12 | H.C. WainwrightSwayampakula Ramakanth | $5 | 52.4% upside | |
| 2025-04-15 | Industrial Alliance SecuritiesJames Molloy | $90 | 2643.9% upside | |
| 2024-07-17 | EF HuttonJason Kolbert | $200 | 5997.6% upside | |